STRS Ohio’s Xenon Pharmaceuticals XENE Stock Holding History

STRS Ohio’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$833K	Buy	13,800 +8,100	+142%	+$450K	﹤0.01%	813
2026 Q1	$331K	Buy	5,700 +4,400	+338%	+$203K	﹤0.01%	1277
2025 Q4	$58.3K	Buy	+1,300	New	+$54.6K	﹤0.01%	1943

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

STRS Ohio's XENE Position: Q2 2026 in Review

STRS Ohio increased its Xenon Pharmaceuticals (XENE) stake by 142% in Q2 2026, buying an estimated $450K and bringing the position to 13,800 shares worth $833K. The position accounts for ﹤0.01% of the portfolio, ranked #813.

STRS Ohio first reported a position in XENE in Q4 2025 and has held it in 3 quarters since. 316 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

STRS Ohio held 13,800 shares of Xenon Pharmaceuticals worth $833K as of Q2 2026.
STRS Ohio bought 8,100 Xenon Pharmaceuticals shares in Q2 2026, an estimated $450K.
Xenon Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #813 holding.
STRS Ohio first reported a position in Xenon Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
316 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.